Company Information

CHANDRA BHAGAT PHARMA LTD.

NSE : NABSE : 542934ISIN CODE : INE07QQ01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE114.850 (0 %)
PREV CLOSE ( ) 114.85
OPEN PRICE ( ) 114.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7000
TODAY'S LOW / HIGH ( )114.85 114.85
52 WK LOW / HIGH ( ) 80160
NSE
This Company is not listed in NSE
ChairmanHemant Chandravadan Bhagat
Managing DirectorHemant Chandravadan Bhagat
Company SecretaryRajni Dawani
Executive DirectorPrachi Pranav Bhagat
Non Executive Independent DirectorRavindra Gajanan Awati
Abha Praveen Doshi
Whole Time DirectorPranav Hemant Bhagat
Incorporation Year : 10-03 2003

Registered Office :

Address : Flat No. 1 & 2, Gr. Floor, 323,F, Bhagat Bhuvan Dr. Ambedkar Road,Matunga (East) Mumbai,
Maharashtra-400019 .

Phone : 022-24146154 / 24157205 / 24129162

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.